Live Cell Imaging Market To Reach USD 3.76 Billion By 2026 | Reports And Data

Live Cell Imaging Market Size – USD 1.86 Billion in 2018, Market Growth - CAGR of 9.1%, Live Cell Imaging Industry Trends – Product launches and research for Technological progressions

New York, New York, UNITED STATES

New York, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Factors contributing to the growing CAGR are rising incidences of cancer, diabetes and cardiovascular disorders worldwide, adoption of high-content screening techniques and huge government funding for cell-based research along with government rules, regulations and interventions

Based on the analysis, the global live cell imaging market was valued at USD 1.86 billion in 2018 and is expected to reach USD 3.76 billion by year 2026, at a CAGR of 9.1%. A technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes is termed live cell imaging. Live cell imaging techniques allow scientists to observe cell structures and processes in real time, and over time. Moreover, the spatial resolution of light microscopy allows observing subcellular structures, by using a range of fluorescent probes. Besides, since live cell imaging is less prone to experimental artifacts, it usually provides more reliable and relevant information than fixed cell microscopy. The observation of dynamic changes provides more insight into the operations of a cell than a snapshot provided by imaging fixed cells. Live-cell imaging chambers must fulfill a variety of requirements in order to be successfully employed in experiments. Live cell imaging has wide areas of application and it can be used to comprehend active processes and cellular structures. Live cell imaging is also used for the study of study cellular integrity, protein trafficking, enzyme activity, localization of molecules, exocytosis and endocytosis among others.

Factors acting as market drivers include, the live cell imaging technique that is gradually being applied by pharmaceutical companies to develop personalized medicine and the pharmaceutical companies are progressively using live cell imaging in research and development in order to develop new medicines. Moreover, live cell imaging is better, relevant and reliable than fixed cell microscopy. On the other hand, lack of availability of skilled professionals and high content screening systems may hinder the growth of the market.     

Request free sample of this research report at:

Further key findings from the report suggest

  • According to the World Health Organization (WHO), chronic disease is predictable to increase by 57% by the year 2020. Increasing prevalence of chronic disease demanding higher & quicker diagnostic facilities boost the growth of live cell imaging market
  • Based on the product, the market is segmented into instruments, consumable, and software used in live cell imaging. Instrument segment dominated the market with market share of roughly 39.1%, which was followed by the consumables
  • North American market will dominate the market due to investments and funding available for research in this field is the key driver in this region. North America held largest market share of 43.8% in the year 2018 and will continue to dominate the live cell imaging market during the forecast period
  • Merck launched a new microfluidic system, CellASIC ONIX2, intended to be used for live cell imaging. The product is perceived to offer better cell manipulation techniques and stable imaging conditions. Such product launches are likely to prosper the growth of live cell imaging market
  • Asia Pacific registered highest CAGR of 10.2% due to rising awareness regarding cancer, diabetes and cardiovascular diseases along with initiatives taken by the governments in the region to encourage the treatment of the disease
  • Owing to the increasing number of researchers working on molecular interaction networks, cell biology dominated the application segment with a market share of around, 43.3%
  • Ranging in complexity from the simple preparation of a sealed coverslip on a microscope slide to sophisticated perfusion chambers that enable tight control of virtually all environmental variables, culture chambers are designed to allow living specimens to be observed with minimal invasion at high resolution
  • Live-cell imaging chambers are produced in a wide variety of configurations that often utilize entirely different technologies for maintaining the specimen at a constant temperature. For instance, chambers featuring coverslips that are heated with a conductive coating usually produce superior thermal consistency across the glass surface
  • Key players in the live cell imaging market include Carl Zeiss, Meditec AG, Leica Microsystems, Nikon Corporation, Becton, Dickinson and Company, GE Healthcare, Olympus Corporation, Thermo Fisher Scientific, Sigma-Aldrich Corporation, PerkinElmer and Molecular Devices

To identify the key trends in the industry, click on the link below:

Segments covered in the report:

For the purpose of this study, Reports and Data have segmented the global live cell imaging market on the basis of product type, application, technology end use, and region:                     

Product (Revenue, USD Million; 2016–2026)

  • Instruments
    • Microscopes
    • Cell analyzers
    • Image capturing
  • Consumables
  • Software
  • Other

Application (Revenue, USD Million; 2016–2026)

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery
  • Other

Technology (Revenue, USD Million; 2016–2026)

  • Fluorescence resonance energy transfer (FRET)
  • Time lapse Microscopy
  • Fluorescence recovery after photobleaching (FRAP)
  • High content screening (HCS)
  • Others

End Use (Revenue, USD Million; 2016–2026)

  • Pharmaceutical and Biotechnology Companies
  • Research Institutes
  • Hospitals
  • Diagnostic Laboratories
  • Other

Order Now:
Regional Outlook (Revenue in USD Million; 2016–2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Latin America
  • Brazil

Browse more similar reports on Pharma and Healthcare category by Reports And Data

Cetuximab Market -

Fluorouracil Market -

Palbociclib Market -

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.


Contact Data